{
    "clinical_study": {
        "@rank": "13174", 
        "acronym": "SABIO", 
        "arm_group": {
            "arm_group_label": "CPAP treatment", 
            "arm_group_type": "Experimental", 
            "description": "67 consecutive male patients with OSA were recruited: 36 with mild-moderate OSA and 31 with severe OSA. Data were collected in all subjects at baseline and after 1 month of CPAP."
        }, 
        "brief_summary": {
            "textblock": "Reduced plasma nitrate (NOx) levels and increased urinary norepinephrine (U-NE) levels have\n      been described in severe obstructive sleep apnea (OSA), and are reverted by continuous\n      positive airway pressure (CPAP). The investigators wanted to know the effect of CPAP on\n      these biomarkers in mild-moderate OSA."
        }, 
        "brief_title": "Efficacy Study of CPAP on Nitrate and Norepinephrine Levels in Severe and Mild-moderate Sleep Apnea (SABIO)", 
        "completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators aimed to compare NOx and U-NE levels and blood pressure (BP) between male\n      patients with mild-moderate and severe OSA and determine the impact of 1 month of CPAP\n      therapy on these parameters.\n\n      The investigators undertook a prospective study of 67 consecutive OSA patients (36\n      mild-moderate, 31 severe). Measurements of plasma NOx at 11 pm, 4 am and 7 am, 24-h U-NE and\n      ambulatory BP were obtained at baseline and after 1 month of CPAP."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Diagnosis of obstructive sleep apnea\n\n        Exclusion Criteria:\n\n          -  current smoker\n\n          -  respiratory disease\n\n          -  cardiac disease (except for arterial hypertension)\n\n          -  renal disorder\n\n          -  hepatic disorder\n\n          -  psychiatric disorder\n\n          -  diabetes mellitus\n\n          -  dyslipidemia\n\n          -  rhinitis\n\n          -  sinusitis\n\n          -  acute illness\n\n          -  daytime hypoxemia or hypercapnia\n\n          -  therapy with oral nitrates\n\n          -  therapy with angiotensin-converting enzyme inhibitors\n\n          -  therapy with beta-blockers\n\n          -  therapy with statins\n\n          -  therapy with non-steroidal anti-inflammatory drugs\n\n          -  presence of central respiratory events\n\n          -  previous CPAP therapy\n\n          -  previous uvulopalatopharyngoplasty"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "67", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769807", 
            "org_study_id": "CEDOC", 
            "secondary_id": "Funda\u00e7\u00e3o Ci\u00eancia e Tecnologia"
        }, 
        "intervention": {
            "arm_group_label": "CPAP treatment", 
            "description": "CPAP adaptation was performed by a sleep technician and the patients were instructed to use this for 1 month.", 
            "intervention_name": "CPAP", 
            "intervention_type": "Device", 
            "other_name": "Automated pressure setting device (AutoSet Spirit, ResMed)"
        }, 
        "intervention_browse": {
            "mesh_term": "Norepinephrine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sleep apnea", 
            "CPAP treatment", 
            "Plasma nitrate", 
            "Urinary norepinephrine", 
            "Blood pressure"
        ], 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lisbon", 
                    "country": "Portugal", 
                    "zip": "1769-001"
                }, 
                "name": "Hospital Pulido Valente"
            }
        }, 
        "location_countries": {
            "country": "Portugal"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of CPAP on Nitrate and Norepinephrine Levels in Severe and Mild-moderate Sleep Apnea", 
        "overall_official": {
            "affiliation": "University of Lisbon", 
            "last_name": "Paula G Pinto, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Portugal: Ethics Committee for Clinical Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "After sleep apnea diagnosis, measurements of plasma NOx at 11 pm, 4 am and 7 am were obtained at baseline and after 1 month of CPAP.", 
            "measure": "Plasma nitrate (NOx) levels", 
            "safety_issue": "No", 
            "time_frame": "one month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769807"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Lisbon", 
            "investigator_full_name": "Paula Pinto", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Ambulatory BP were obtained at baseline and after 1 month of CPAP.", 
                "measure": "24 h Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "one month after CPAP"
            }, 
            {
                "description": "After sleep apnea diagnosis, measurements of urinary norepinephrine levels were obtained at baseline and after 1 month of CPAP.", 
                "measure": "Urinary norepinephrine (U-NE) levels", 
                "safety_issue": "No", 
                "time_frame": "One month"
            }
        ], 
        "source": "University of Lisbon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Lisbon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2004", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}